Among patients with Clostridium difficile infection (CDI) who recovered following standard treatment with the antibiotics metronidazole or vancomycin, oral administration of spores of a strain of C. difficile that does not produce toxins colonized the gastrointestinal tract and significantly reduced CDI recurrence, according to a new study.